Symposium 8 Three-Year Follow-Up of the Safety and Feasibility of
Intramyocardial Bone Marrow Mononuclear Cell Implantation in Patients
with Ischemic Heart Disease
Kimikazu Hamano
Figure 4. Intramyocardial
implantation of preprogrammed bone marrow stem cells.
